Trefoil peptides: Mitogens, motogens, or mirages?

Journal of Clinical Gastroenterology

Volumn 25, Issue SUPPL. 1, 1997, Pages

  Modlin, Irvin M ^a,b   Poulsom, Richard ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Morphogens; Motogens; Mucous interactions; Restitution; Trefoil peptides; Ulcer healing; Ulcer treatment

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INDOMETACIN; MESSENGER RNA; MITOGENIC AGENT; MORPHOGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR ALPHA; TREFOIL PEPTIDE;

ANASTOMOSIS; BRUNNER GLAND; CELL MIGRATION; CONFERENCE PAPER; GOBLET CELL; HUMAN; MITOGENESIS; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EPITHELIUM; STOMACH GLAND; STOMACH MUCOSA LESION; ULCER HEALING; WOUND HEALING;

ANIMALS; CELL MOVEMENT; GASTRIC MUCOSA; GROWTH SUBSTANCES; HUMANS; INTESTINAL MUCOSA; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; PARASYMPATHOLYTICS; PEPTIC ULCER; PEPTIDES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031430973     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199700001-00016     Document Type: Conference Paper

References (53)

1. Thim L. A new family of growth factor-like peptides. "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989;250:85-90.
2. Poulsom R. Trefiol peptides. In: Goodlad RA, Wright NA, eds. Cytokines and growth factors. London: Bailliere Tindall, 1996:113-134.
3. Poulsom R, Wright NA. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993;265:G205-13.
4. Jørgensen KH, Thim L, Jacobsen HE. Preparation and characterization of PSP, a new polypeptide from porcine pancreas [Abstract]. Diabetologia 198121:288.
5. Jørgensen KH, Thim L, Jacobsen HE. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 1982;3:207-19.
6. Hoosein NM, Thim L, Jørgensen KH, Brattain MG. Growth stimulatory effect of pancreatic spasmolytic polypeptides on cultured colon and breast tumor cells. FEBS Lett 1989;247: 303-6.
7. Jørgensen KD, Diamant B, Jørgensen KH, Thim L. Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul Pept 1982;3:231-43.
8. Frandsen EK, Jørgensen KH, Thim L. Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity. Regul Pept 1986;16:291-7.
9. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105: 1110-6.
10. Thim L, Norris K, Norris F, et al. Purification and characterisation of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett 1993;318:345-52.
11. Masiakowski P, Breathnach R, Bloch J, Cannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982;10:7895-903.
12. Rio M, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988;241:705-8.
13. Kida N, Yoshimura T, Mori K, Hayashi K. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7). Cancer Res 1989;49:3494-8.
14. Tomasetto C, Wolf C, Rio M, et al. Breast cancer protein pS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol Endocrinol 1989;3:1579-84.
15. Lefebvre O, Wolf C, Kédinger M, et al. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol 1993;122:191-8.
16. Williams R, Stamp GWH, Gilbert C, Pignatelli M, Lalani E-N. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J Cell Sci 1996;109:63-71.
17. Miyashita S, Nomoto H, Konishi H, Hayashi K. Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay. Clin Chim Acta 1994;228:71-81.
18. Chadwick MP, May FEB, Westley BR. Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser 58. Biochem J 1995;308:1001-7.
19. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991;88:11017-21.
20. Podolsky DK, Pleskow DK, Jafari H. Latent transformed growth-inhibiting factor in human malignant effusions. Cancer Res 1988;48:418-24.
21. Chinery R, Poulsom R, Rogers LA, et al. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem J 1992;285:5-8.
22. Hauser F, Poulsom R, Chinery R, et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed in the ulcer associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993;90:6961-5.
23. Podolsky DK, Lynch-Devaney K, Stow JL, et al. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:6694-702.
24. Theisinger B, Seitz G, Dooley S, Welter C. A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer. Breast Cancer Res Treat 1995;38:145-51.
25. Probst JC, Skutella T, Müller-Schmid A, Jirikowski GF, Hoffmann W. Molecular and cellular analysis of rP1.B in the rat hypothalamus: in situ hybridization and immunohistochemistry of a new P-domain neuropeptide. Mol Brain Res 1995;33: 269-76.
26. Mashimo H, Podolsky DK, Fishman MC. Structure and expression of murine intestinal trefoil factor: high evolutionary conservation and postnatal expression. Biochem Biophys Res Commun 1995;210:31-7.
27. Thim L, Woldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995; 34:4757-64.
28. Cox HM, Chinery R, Wright NA. An epithelial ion transport role for intestinal trefoil factor but not for pancreatic spasmolytic polypeptide. Regul Pept 1993;47:90.
29. Wright NA, Poulsom R, Stamp GW, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162: 279-84.
30. Playford RJ. Peptides and gastrointestinal mucosal integrity. Gut 1995;37:595-7.
31. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mocosal ulceration in gastrointestinal stem cells. Nature 1990;343:82-5.
32. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
33. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor, and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175:405-14.
34. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
35. Chinery R, Playford R. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 1995;88:401-3.
36. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 1996;110:489-97.
37. Poulsom R, Begos DE, Modlin IM. Molecular aspects of restitution: functions of trefoil peptides. Yale J Biol Med [in press].
38. De A, Brown DG, German MA, Carr M, Sanderson MR, Freemont PS. Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. Proc Natl Acad Sci USA 1994;91:1084-8.
39. Kato K, Chen MC, Lehman F, et al. Trefoil peptides, IGF-I and basic FGF stimulate restitution in primary cultures of canine oxyntic mucosal cells. Gastroenterology 1995;108: A130-A130.
40. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994;94:376-83.
41. Huttenlocher A, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol 1995;7:697-706.
42. Hanby AM, Chinery R, Poulsom R, Playford RJ, Pignatelli M. Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 1996; 148:723-9.
43. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996;93:2137-42.
44. Lefebvre O, Chenard MP, Masson R, et al. Gastric-mucosa abnormalities and tumorigenesis in mice lacking the ps2 trefoil protein. Science 1996;274:259-62.
45. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
46. Chinery R, Cox HM. Modulation of epdiermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br J Pharmacol 1995;115:77-80.
47. Chinery R, Bates PA, De A, Freemont PS. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett 1995; 357:50-4.
48. Rasmussen TN, Thim L, Raaberg L, Harling H, Holst JJ. Pancreatic spasmolytic polypeptide, a potential growth factor for the intestine: localization and control of secretion [Abstract]. Digestion 1990;46:90.
49. Chinery R, Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide intestinal trefoil factor. Peptides 1995;16:749-55.
50. Chinery R, Poulsom R, Elia G, Hanby AM, Wright NA. Expression and purification of a trefoil peptide motif in a β-galactosidase fusion protein and its use to search for trefoil binding sites. Eur J Biochem 1993;212:557-63.
51. Gajhede M, Petersen TN, Henriksen A, et al. Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1993;1:253-62.
52. Cavailles V, Garcia M, Rochefort H. Regulation of cathespin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 1989;3: 552-8.
53. Miyashita S, Hirota M, Yamamoto T, Shiroyama C, Furukawa Y, Hayashi K. Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7). Eur J Biochem 1994;225:1041-6.